Rathbones Group PLC Takeda Pharmaceutical CO LTD Transaction History
Rathbones Group PLC
- $22 Billion
- Q2 2025
Shares
1 transactions
Others Institutions Holding TAK
# of Institutions
368Shares Held
73.1MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$185 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$106 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$62.5 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$55.9 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$51.5 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.2B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...